Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Compliance Ref | Federal-State | Inspection Ref | Import Program | Science Ref | ORA Search


Inspection References
Investigations Operations Manual 2004
Document TOC | Chapter TOC


510-B - FORM FDA 483 (2 pgs)

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION

DISTRICT OFFICE ADDRESS AND PHONE NUMBER
Minneapolis District
240 Hennipin Ave.
Minneapolis, MN 55401
(612) 787-3904
DATE(S) OF INSPECTION
1/5-7/Begin Changed Text2004End Changed Text
FEI NUMBER
0000112233
NAME AND TITLE OF INDIVIDUAL TO WHOM REPORT IS ISSUED
TO: William S. Gundstrom, Vice President, Production
FIRM NAME
Topline Pharmaceuticals "T.L.P. "
STREET ADDRESS
2136 Elbe Place
CITY, STATE AND ZIP CODE
Jackston, MN 55326
TYPE OF ESTABLISHMENT INSPECTED
Tablet Repacker
Begin Changed Text THIS DOCUMENT LISTS OBSERVATIONS MADE BY THE FDA REPRESENTATIVE(S) DURING THE INSPECTION OF YOUR FACILITY. THEY ARE INSPECTIONAL OBSERVATIONS, AND DO NOT REPRESENT A FINAL AGENCY DETERMINATION REGARDING YOUR COMPLIANCE. IF YOU HAVE AN OBJECTION REGARDING AN OBSERVATION, OR HAVE IMPLEMENTED, OR PLAN TO IMPLEMENT, CORRECTIVE ACTION IN RESPONSE TO AN OBSERVATION, YOU MAY DISCUSS THE OBJECTION OR ACTION WITH THE FDA REPRESENTATIVE(S) DURING THE INSPECTION OR SUBMIT THIS INFORMATION TO FDA AT THE ADDRESS ABOVE. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT FDA AT THE PHONE NUMBER AND ADDRESS ABOVE.End Changed Text

DURING AN INSPECTION OF YOUR FIRM (I) (WE) OBSERVED:

List your observations in a logical and concise manner.


(See IOM 512, 512.01, & 512.02)

SEE REVERSE OF THIS PAGE

EMPLOYEE(S) SIGNATURE

Sidney H. Rogers

EMPLOYEE(S) NAME AND TITLE (Print or Type)

Sidney H. Rogers, Investigator

DATE ISSUED

1/7/Begin Changed Text2004End Changed Text

FORM FDA 483 (Begin Changed Text 4/03End Changed Text) PREVIOUS EDITION OBSOLETE INSPECTIONAL OBSERVATIONS

Reverse Text on Page:

The observations of objectional conditions and practices listed on the front of this form are reported:

  1. Pursuant to Section 704(b) of the Federal Food, Drug and Cosmetic Act, or
  2. To assist firms inspected in complying with the Acts and regulations enforced by the Food and Drug Administration.
Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21 USC374(b)) provides:

"Upon completion of any such inspection of a factory, warehouse, consulting laboratory, or other establishment, and prior to leaving the premises, the officer or employee making the inspection shall give to the owner, operator, or agent in charge a report in writing setting forth any conditions or practices observed by him which, in his judgement, indicate that any food, drug, device, cosmetic in such establishment (1) consists in whole or in part of any filthy, putrid, or decomposed substance or (2) has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health. A copy of such report shall be sent promptly to the Secretary."

 

Page Top Document TOC | Chapter TOC |